Wei H-J, Wu ATH, Hsu C-H, Lin Y-P, Cheng W-F, Su C-H, Chiu W-T, Whang-Peng J, Douglas FL, Deng W-P.  2011.  The development of a novel cancer immunotherapeutic platform using tumor-targeting mesenchymal stem cells and a protein vaccine.. Mol Ther. 19(12):2249-57.

Simon MC, Rooney RJ, Fisch TM, Heintz N, Nevins JR.  1990.  E1A-dependent trans-activation of the c-fos promoter requires the TATAA sequence.. Proc Natl Acad Sci U S A. 87(2):513-7.